| 11 |
2023 |
국내 |
Advancing Cardio-Oncology in Asia
|
심장종양학연구회 |
|
|
| 10 |
2022 |
ESC |
ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|
심장종양학연구회 |
|
|
| 9 |
2020 |
국내 |
Cardiovascular Complications of Novel Anti-Cancer Immunotherapy: Old Problems from New Agents?
|
심장종양학연구회 |
|
|
| 8 |
2020 |
ACC/AHA |
Cardiovascular toxicity related to cancer treatment_a pragmatic approach to the American and European cardio-oncology guidelines
|
심장종양학연구회 |
|
|
| 7 |
2020 |
ESMO |
Management of cardiac disease in cancer patients throughout oncological treatment_ESMO recommendations
|
심장종양학연구회 |
|
|
| 6 |
2019 |
ESC |
Monitoring the heart during cancer therapy
|
심장종양학연구회 |
|
|
| 5 |
2018 |
ASCO |
Management of Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|
심장종양학연구회 |
|
|
| 4 |
2018 |
국내 |
Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography
|
심장종양학연구회 |
|
|
| 3 |
2017 |
ESMO |
Cardiovascular disease in survivors of childhood cancer_insights into epidemiology, pathophysiology, and prevention
|
심장종양학연구회 |
|
|
| 2 |
2017 |
ASCO |
Prevention and monitoring of cardiac dysfunction in survivors of adult cancers_ASCO guideline
|
심장종양학연구회 |
|
|
| 1 |
2016 |
ESC |
Cancer treatments and cardiovascular toxicity_2016 ESC guideline
|
심장종양학연구회 |
|
|
